Exchange & Returns Information
Review Details
(61)
| Generic For | TOPAMAX |
|---|---|
| Active Ingredient | TOPIRAMATE |
| Strength | 100MG |
| Manufacturer | JANSSEN PHARMACEUTICALS |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 100 TABLETS | $ 0.82 | $ 81.90 |
$ 69.62
Apply ZARVY26 (-15%)
You save $ 12.29
|
||
| 2 BOXES - 200 TABLETS | $ 0.76 |
7% $ 163.80
$ 151.90
|
$ 129.12
Apply ZARVY26 (-15%)
You save $ 22.79
|
||
| ★ Best Value 3 BOXES - 300 TABLETS | $ 0.74 |
10% $ 245.70
$ 221.90
|
$ 188.62
Apply ZARVY26 (-15%)
You save $ 33.29
|
Reference information will be available soon.
Topamac 100 is a high-strength topiramate tablet containing 100mg of the active ingredient, designed for patients requiring more intensive neurological stabilization or behavioral modulation. As a broad-spectrum anticonvulsant, topiramate is clinically approved for epilepsy and migraine prophylaxis, working through multiple pathways to dampen neuronal hyperexcitability. In recent years, it has gained attention for its off-label utility in smoking cessation—especially in patients with impulse control issues, alcohol use disorders, or those who have not responded to standard therapies. Topamac 100 provides an effective and efficient dosing option for titration and maintenance in both neurological and off-label behavioral applications.
- Sleep & Mental Health > Epilepsy Topiramate is indicated as a first-line or adjunctive therapy for partial-onset and generalized tonic-clonic (GTC) seizures, including those associated with Lennox-Gastaut syndrome. It modulates excitatory and inhibitory neurotransmitters, stabilizing neuronal firing across multiple brain regions. The 100mg strength is particularly useful for patients requiring higher maintenance doses in monotherapy or complex seizure cases. - Painkillers & Headache > Migraine Topiramate serves as a long-term preventive treatment for migraine headaches. It does not act on acute migraine pain but significantly reduces the frequency and severity of attacks over time. By regulating pain pathways and reducing cortical hyperexcitability, it enhances quality of life in chronic migraine sufferers. - Smoking Cessation Treatment > Others (off-label cognitive impulse modulation) Topiramate’s impact on the dopamine reward system has made it a promising off-label option for smoking cessation. It reduces the reinforcing effects of nicotine, leading to diminished cravings and improved abstinence rates. Topamac 100 is suitable for patients advancing into the higher-dose phase of cessation protocols, particularly those with a history of substance dependence or behavioral dysregulation.
Topiramate exerts its therapeutic effects via a multi-modal mechanism: enhancement of GABA-A mediated inhibition, inhibition of AMPA/kainate glutamate receptors, voltage-gated sodium channel blockade, and mild carbonic anhydrase inhibition. This combination leads to decreased neuronal hyperexcitability, stabilized mood and behavior, and suppressed addictive drive. Its non-addictive profile and wide efficacy range make it applicable to both chronic neurologic management and short-term behavioral intervention programs like smoking cessation.
Topiramate should be titrated slowly to minimize adverse effects while optimizing efficacy, especially in high-dose forms like 100mg. → Epilepsy - Monotherapy (Immediate-Release): • Week 1: 25 mg twice daily • Increase weekly to 200 mg twice daily (400 mg/day) by Week 6 - Monotherapy (Extended-Release): • Week 1: 50 mg once daily • Increase weekly to 400 mg once daily by Week 6 - Adjunctive Therapy (Immediate-Release): • Start: 25–50 mg once daily • Increase weekly to 200–400 mg/day in 2 divided doses - Adjunctive Therapy (Extended-Release): • Start: 25–50 mg once daily • Increase weekly to 200–400 mg once daily → Migraine Prophylaxis - Immediate-Release: • Week 1: 25 mg at bedtime • Increase weekly to 50 mg twice daily (100 mg/day) by Week 4 - Extended-Release: • Week 1: 25 mg once daily • Increase weekly to 100 mg once daily by Week 4 → Lennox-Gastaut Syndrome (Adjunct): - Immediate or Extended-Release: • Start: 25–50 mg/day • Increase weekly to 200–400 mg/day in 1–2 divided doses → Smoking Cessation (Off-label Use): - Week 1: 25 mg once daily (preferably at bedtime) - Week 2: 50 mg once daily - Week 3: 75 mg once daily - Week 4: 100 mg once daily - Week 5: 150 mg once daily - Week 6: 200 mg once daily - Week 7–8: Up to 300 mg once daily, depending on patient response → Duration: Smoking cessation treatment typically lasts 8 to 12 weeks. Long-term continuation should be based on medical evaluation. → Administration: Take once daily, with or without food. Bedtime administration is preferred to minimize fatigue and cognitive slowing. → Combination Therapy: May be combined with nicotine replacement therapy or bupropion under supervision. Monitor for additive CNS effects such as sedation, confusion, or irritability. → Discontinuation: Taper the dose gradually over 1–2 weeks to prevent rebound seizures or withdrawal symptoms.
Store in a dry, cool location, avoiding heat and direct sunlight. Keep below 25°C and ensure bottle is sealed tightly after use. Keep out of reach of children. Do not use tablets past expiration date.
Common: fatigue, dizziness, paresthesia, appetite loss, cognitive dulling Less common: speech difficulties, taste changes, irritability, kidney stones Serious: suicidal ideation, metabolic acidosis, visual field defects Contact your healthcare provider if mood changes, vision disturbances, or confusion occur.
きちんと届きました。梱包も丁寧です。
ได้รับภายในสิบวัน แพ็คดีไม่มีเสียหาย
追跡が細かくて助かりました。次回も利用します。
Significantly cheaper than local pharmacy.
Came quicker than I expected.
No combo deals available at the moment.
